Could a Methyl Group Predict Your Risk of Depression?
Keywords:MDD, Epigenetics, Biomarker, Serotonin
Major Depressive Disorder (MDD) is a systemic condition that diminishes the daily quality of life of those affected. There are no current methods that can reliably diagnose depression on a biochemical level. The premise of this work is to report on a potential biochemical marker, DNA methylation of the serotonin transporter gene (5-HTT). This biochemical marker can serve as an indicator of gene expression patterns, ultimately leading to a neurochemical imbalance in affected individuals. Studying this biomarker has the potential to improve diagnostic and therapeutic techniques in the future, and improve the prognosis of those with MDD.
How to Cite
Authors submitting to the journal must adhere to the terms of Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license as outlined below:
1. You are free to share (copy and redistribute) any material from this journal, granted you have given appropriate credit, provided the link to the license, and indicated whether changes were applied to original work.
2. You are free to adapt (remix, transform, and build upon) any material from this journal, granted you distribute your work under the same license.